# Pimavanserin Treatment in TS

> **NCT04794413** · EARLY_PHASE1 · COMPLETED · sponsor: **Joseph Jankovic** · enrollment: 10 (actual)

## Conditions studied

- Tourette Syndrome
- Tardive Dyskinesia

## Interventions

- **DRUG:** Pimavanserin

## Key facts

- **NCT ID:** NCT04794413
- **Lead sponsor:** Joseph Jankovic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-12
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04794413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04794413, "Pimavanserin Treatment in TS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04794413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*